CBD-Intel will provide comprehensive market and legal analysis as well as a daily news service, and like ECigIntelligence, it will be based on a paid subscription model. The online publication and research resource was launched this week and will be the first to focus on the fast-growing CBD industry in Europe and worldwide.
CBD, or cannabidiol, is the legal extract of the cannabis plant which is used for the treatment of a number of health conditions. Despite derived from Cannabis, it does not induce the physical dependence or altered states of consciousness associated with its consumption.
Recent WHO report recognizes the medical applications of CBD oil
CBD-Intel aims to provide coverage of the topic by drawing on a large team of legal and market analysts, reporters and editors, in different countries. “With ECigIntelligence we have found that a rapidly-developing industry has an urgent need for authoritative, unbiased, in-depth coverage of markets and regulation,” said managing director Tim Phillips.
“We believe that the CBD industry across Europe and the world will benefit from exactly the same approach – reporting and analysis that is intelligent, insightful and independent.”